Human Serum Amyloid A-4 Protein SAA4
- Known as:
- Human Serum Amyloid A-4 Protein SAA4
- Catalog number:
- C5l0
- Product Quantity:
- l0
- Category:
- -
- Supplier:
- Novoprotein
- Gene target:
- Human Serum Amyloid A-4 Protein SAA4
Related genes to: Human Serum Amyloid A-4 Protein SAA4
- Gene:
- SAA4 NIH gene
- Name:
- serum amyloid A4, constitutive
- Previous symbol:
- -
- Synonyms:
- C-SAA, CSAA
- Chromosome:
- 11p15.1
- Locus Type:
- gene with protein product
- Date approved:
- 1992-06-12
- Date modifiied:
- 2016-10-05
Related products to: Human Serum Amyloid A-4 Protein SAA4
Related articles to: Human Serum Amyloid A-4 Protein SAA4
- 'Small extracellular vesicles (sEVs) are nanosized, membrane-enclosed sacs released by diverse cell types. They play a critical role in cell-cell communication through their cargo, which includes a wide range of proteins, lipids, and nucleic acids. Physiologically, sEVs circulate in various body fluids such as blood, urine, and saliva, making them accessible for diagnostic via non-invasive isolation techniques. Recent advances in high-throughput proteomics have significantly enhanced our ability to characterize the protein content of sEVs. Importantly, multiple studies on human fluids have identified specific protein markers across different cancer types, encompassing molecules involved in inflammation, cellular adhesion, immunity, and lipoprotein regulation. Interestingly, some of these proteins are consistently detected across multiple cancer types and sample sources, suggesting the existence of a shared "oncogenic signature" that may be transferred via sEVs. Among body fluids, urine and saliva are particularly promising for easy, non-invasive diagnostics. However, these sample types remain underexplored as compared to the serum, leaving substantial opportunities for future research. Taken together, these findings position sEVs as a powerful tool with significant potential for advancing precision cancer care. SIGNIFICANCE: Living cells release nanosized membrane-enclosed vesicles called small extracellular vesicles (sEVs) into the extracellular environment. sEVs contain protein cargo molecules that critically take part in cell-cell communications. Quantitative proteomics identified potential sEV associated biomarkers for early cancer diagnosis and therapy. sEV Proteins associated with cell adhesion and inflammation, lipoproteins and immunoglobulins are potential molecules that were majorly identified. Interestingly, some of these proteins such as APOA4, SAA4, ITIH4, SERPINC1 and VWF were consistently identified across multiple cancer types and sample sources, highlighting their potential as future biomarkers. - Source: PubMed
Publication date: 2026/03/08
Pandey DivyaTiwari VineetaGhosh Dipanjana - Glioma is the most aggressive primary brain tumor with glioblastoma (GBM, IDH-wildtype) as its most malignant subtype, and is associated with a dismal prognosis, creating an urgent need for noninvasive biomarkers to enable early detection and prognostic stratification. Single-marker detection exhibits inherent limitations in clinical practice, whereas multi-marker panels hold greater promise for enhancing diagnostic efficacy. - Source: PubMed
Publication date: 2026/02/17
Meng WeiDuan JianGuo ChengchengXu JiangZheng SuyueWu Haibin - To elucidate the proteome profile of cartilage tissue with two distinct phenotypes namely varus and valgus osteoarthritic (OA) knees in response to different loading conditions. - Source: PubMed
Publication date: 2025/05/21
Soundarrajan DhanasekaranArunachalam DivyaNayagam Sharon MiracleThangavel ChitraRajasekaran Shanmuganathan - Metformin is one of the most used drugs worldwide. Given the increasing use of proteomics in trials, bioresources, and clinics, it is crucial to understand the influence of metformin on the levels of the circulating proteome. - Source: PubMed
Publication date: 2025/07/19
Connolly BenMcCreight LauraSlieker Roderick CBedair Khaled FDonnelly Louisede Klerk Juliette ABeulens Joline W JElders Petra J MBergström GöranHong Mun-GwanKoivula Robert WFranks Paul WSchwenk Jochen MGummesson AndersPearson Ewan R't Hart Leen M - Neuroinflammation and oxidative dysfunction, and their reciprocal interplay, are critically involved in the pathophysiology of chronic neuropathic pain (NeuP). Numerous studies have investigated the crosstalk between inflammatory biomolecules such as cytokines, chemokines, and neuronal cells. However, the impact of immunomodulatory lipoproteins and oxylipins in NeuP pathophysiology is far less explored. - Source: PubMed
Publication date: 2025/07/02
Jönsson MikaBäckryd EmmanuelLjunggren StefanOttosson NinaJauregi-Miguel AmaiaLiin Sara ICheca AntonioWheelock Craig EGhafouri Bijar